Literature DB >> 11068557

Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.

C C Chang1, C Eshoa, B Kampalath, V B Shidham, S Perkins.   

Abstract

The present study was designed to evaluate the lineage differentiation (particularly monocytic differentiation) of immature myeloid cells in granulocytic sarcoma (GS) by immunohistochemistry and correlate the results with lineage differentiation of blasts in the bone marrow and to determine the degree of maturation of the infiltrating myeloid cells in GS by immunohistochemistry using CD34 and HLA-DR. Immunohistochemical stains were performed on paraffin-embedded tissue from 17 GS lesions with lineage-associated markers: myeloperoxidase, CD68 (KP1), CD68 (PG-Ml), glycophorin A, factor VIII, and CD56; and with markers for blasts and immature myeloid cells: CD34 and HLA-DR. Our results show that positive staining with PG-M1, but not KP1, suggests monocytic differentiation of myeloid cells in GS and correlates with the monocytic differentiation of blasts in the bone marrow. Expression of CD56 is frequent in GS, especially when the marrow blasts have monocytic differentiation, and should not be interpreted as a primary natural-killer cell process. The immature myeloid cells in GS are frequently HLA-DR positive. However, CD34 positivity of the immature myeloid cells is relatively uncommon, except in cases with underlying myelodysplastic syndrome or chronic myelogenous leukemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068557     DOI: 10.1309/WWW7-DG6X-HC16-D7J2

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Multiple Jejunal Myeloid Sarcomas Presenting with Intestinal Obstruction in a Non-leukemic Patient: A Case Report with Ultrastructural Observations.

Authors:  Na Rae Kim; Woon Kee Lee; Jong In Lee; Hyun Yee Cho
Journal:  Korean J Pathol       Date:  2012-12-26

2.  Therapy-related, mixed-lineage leukaemia translocation-positive, monoblastic myeloid sarcoma of the uterus.

Authors:  Vinod Pullarkat; Leslie Veliz; Karen Chang; Ann Mohrbacher; Anna Lizza Teotico; Stephen J Forman; Marilyn L Slovak
Journal:  J Clin Pathol       Date:  2007-05       Impact factor: 3.411

3.  Myeloid Sarcoma of the peritoneum at older ages: A case report and review of literature.

Authors:  Mozaffar Aznab; Naser Kamalian; Omid Beiki; Farhad Naleini
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

4.  Myeloid sarcoma presenting with leukemoid reaction in a child treated for acute lymphoblastic leukemia.

Authors:  Aylin Canbolat Ayhan; Cetin Timur; Seyma Sonmez; Ebru Zemheri; Asım Yoruk
Journal:  Case Rep Hematol       Date:  2014-09-03

5.  Myeloid sarcomas: a histologic, immunohistochemical, and cytogenetic study.

Authors:  Borislav A Alexiev; Wenle Wang; Yi Ning; Saranya Chumsri; Ivana Gojo; William H Rodgers; Sanford A Stass; Xianfeng F Zhao
Journal:  Diagn Pathol       Date:  2007-10-31       Impact factor: 2.644

6.  Recurrence of a t(8;21)-Positive Acute Myeloid Leukemia in the Form of a Granulocytic Sarcoma Involving Cranial Bones: A Diagnostic and Therapeutic Challenge.

Authors:  Ambra Di Veroli; Alessandro Micarelli; Mariagiovanna Cefalo; Eleonora Ceresoli; Daniela Nasso; Laura Cicconi; Simone Mauramati; Fabrizio Ottaviani; Adriano Venditti; Sergio Amadori
Journal:  Case Rep Hematol       Date:  2013-09-12

7.  Non-leukemic myeloid sarcoma involving the vulva, vagina, and cervix: a case report and literature review.

Authors:  Yuan Yu; Xuemei Qin; Shuxin Yan; Wenxia Wang; Yanlin Sun; Maohong Zhang
Journal:  Onco Targets Ther       Date:  2015-12-10       Impact factor: 4.147

Review 8.  Clinical characteristics and management of primary granulocytic sarcoma of the oral cavity: A case report and literature review.

Authors:  Yun-Gang Hu; Xiao-Hua Deng; Wei Lei; Xiao-Lin Li
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.